With the issue for the tenth anniversary of SPEKTRUM DER HOMÖOPATHIE we want, as an aid to discussion for our readers, to summarise the state of research and the evidence. For by now homeopathy is denied any evidence in public debate; it is defamed and ridiculed. People are fond of repeating the objectively false argument that there is no scientific proof of homeopathy's effectiveness beyond placebo.
It is a common misunderstanding that evidence-based medicine (EBM) rests solely on scientific studies. As our cover image illustrates, an evidence-based treatment decision involves integrating patients' experiences, expectations and preferences, the clinical expertise of the treating physicians, and the knowledge from studies. A consistently high approval rate in the population over many years indicates many people's preference for homeopathy. SPEKTRUM, in turn, has demonstrated clinical expertise in numerous case reports in recent years.
Four particularly impressive case examples from our international authors further underscore at this level of evidence that homeopathy can also be effective in serious pathologies such as autoimmune hepatitis, cardiomyopathy, multiple sclerosis or systemic lupus erythematosus. Heiner Frei covers all areas of EBM with his work on the treatment of ADHD. Here the preference of patients and their parents, stemming from fears of Ritalin's side effects, combines with the long-standing practical experience of a paediatrician and the results of a widely noted randomised double-blind trial to form a clear evidence-based decision in favour of homeopathic therapy.
Those who, in view of the data, still speak of a placebo effect — our authors who are active in scientific research say — cannot read the data. They have tested the effects of high potencies both in sophisticated experimental plant models in fundamental homeopathic research and in an extensive review of the clinical research. Here the trend in homeopathy, as in other areas of medicine, is towards study designs that investigate the effectiveness of therapeutic interventions under as realistic conditions as possible. Because randomised double-blind studies on the effect of a therapy often yield little insight for clinical application, comparative effectiveness research is now favoured with the aim of enabling specific clinical decisions for patients, as well as for health policy.
For many colleagues, homeopathy as a holistic and immaterial method of treatment cannot be assessed by the standards of scientific-materialistic medicine. But even if the non-material or 'spiritual' effect of a remedy cannot be measured, careful observation and conscientious documentation remain the basis of homeopathic practice and research and will continue to be essential characteristics of our journal and its authors in the future.